Transitional Graduate Membership

Transitional Graduate MembershipAccess tools and resources to prepare for residency.

The ACP Member Directory: Member Connection

Member Connection is a searchable directory of ACP members.

Residency Program Portal Frequently Asked Questions

Residency Program Portal Video Tutorials When I log in, I can't see my roster. What should I do? Please make sure that you are not using Internet Explorer when logging into the RPP. The RPP works best in Chrome, Safari, or Firefox. You will be unable to see or manage your roster using Internet Explorer.

Residency Program Portal

The Enrollment & Outgoing Tabs are Now Open!​Check out the RPP Program Guide for instructions on using the portal.

Reward-a-Resident Program

ACP's Reward-a-Resident Program provides education resources to residency programs that recruit residents to become ACP Resident/Fellow Members.

Residents & Fellows-in-Training Membership Details

Our team routinely works remotely, so mail and fax responses may be delayed. For urgent issues, please contact us directly (phone/email/web chat) for assistance.

Chief Resident Guide: Supporting Residents Through Fellowship Application

William D. Surkis, MD, FACP Internal Medicine Hospitalist Vice President for Medical Affairs Vice President and DIO for Medical Education Lankenau Medical Center, Wynnewood, PA

ACP Herbert S. Waxman Chief Resident Teaching Scholarship

Chief Resident's Corner is an e-newsletter that provides information on internal medicine including abstract competition deadline, resources, etc.

Joseph E. Johnson Leadership Award

Joseph E. Johnson Leadership Award ("Johnson Award") The Joseph E. Johnson Leadership Award was formerly administered by the Council of Resident/Fellow Members and was established by the Board of Regents as a national award on January 11, 2003. Dr. Johnson served as ACP Governor, Regent, Treasurer, Interim Executive Vice President, and Senior Vice President for Membership.

Doctor's Dilemma®

ACP Doctor's Dilemma is a medical jeopardy competition held each year at ACP's annual meeting and available as a mobile game. Learn more.

Time-Restricted Eating for Treatment of Obesity? The Devil Is in the (Counseling) Details

Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans: A Target Trial Emulation: Annals of Internal Medicine: Vol 176, No 11

Background: COVID-19 has been linked to the development of many post–COVID-19 conditions (PCCs) after acute infection. Limited information is available on the effectiveness of oral antivirals used to treat acute COVID-19 in preventing the development of PCCs. Objective: To measure the effectiveness of outpatient treatment of COVID-19 with nirmatrelvir–ritonavir in preventing PCCs. Design: Retrospective target trial emulation study comparing matched cohorts receiving nirmatrelvir–ritonavir versus no treatment. Setting: Veterans Health Administration (VHA). Participants: Nonhospitalized veterans in VHA care who were at risk for severe COVID-19 and tested positive for SARS-CoV-2 during January through July 2022. Intervention: Nirmatrelvir–ritonavir treatment for acute COVID-19. Measurements: Cumulative incidence of 31 potential PCCs at 31 to 180 days after treatment or a matched index date, including cardiac, pulmonary, renal, thromboembolic, gastrointestinal, neurologic, mental health, musculoskeletal, endocrine, and general conditions and symptoms. Results: Eighty-six percent of the participants were male, with a median age of 66 years, and 17.5% were unvaccinated. Baseline characteristics were well balanced between participants treated with nirmatrelvir–ritonavir and matched untreated comparators. No differences were observed between participants treated with nirmatrelvir–ritonavir (n = 9593) and their matched untreated comparators in the incidence of most PCCs examined individually or grouped by organ system, except for lower combined risk for venous thromboembolism and pulmonary embolism (subhazard ratio, 0.65 [95% CI, 0.44 to 0.97]; cumulative incidence difference, −0.29 percentage points [CI, −0.52 to −0.05 percentage points]). Limitations: Ascertainment of PCCs using International Classification of Diseases, 10th Revision, codes may be inaccurate. Evaluation of many outcomes could have resulted in spurious associations with combined thromboembolic events by chance. Conclusion: Out of 31 potential PCCs, only combined thromboembolic events seemed to be reduced by nirmatrelvir–ritonavir. Primary Funding Source: U.S. Department of Veterans Affairs.

Information About Provision of Abortion on U.S. Hospital Websites: A Cross-Sectional Analysis

Personal Actions to Create a Culture of Inclusion: Navigating Difficult Conversations With Medical Colleagues

Microaggressions between members of a team occur often in medicine, even despite good intentions. Such situations call for difficult conversations that restore inclusivity, diversity, and a healthy work culture. These conversations are often hard because of the unique background, experiences, and biases of each person. In medicine, skillful navigation of these interactions is paramount as it influences patient care and the workplace culture. Although much has been published about difficult interactions between providers and patients, significantly less information is available to help navigate provider-to-provider interactions, despite their critical role in improving multidisciplinary patient care teams and organizational environments. This article is intended to serve as a guide for medical professionals who are interested in taking personal responsibility for promoting a safe and inclusive culture by engaging in and modeling difficult conversations with colleagues. The article outlines important considerations to assist with intentional preparation and modulation of responses for all parties involved: conversation initiators, observers of the incident, and conversation receivers. Although these interactions are challenging, together as medical professionals we can approach each other with humility and compassion to achieve our ultimate goal of promoting humanity, not only for our patients but for ourselves and one another.

Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis?

Standards and Ethics Issues in the Determination of Death: A Position Paper From the American College of Physicians

The determination of a patient’s death is of considerable medical and ethical significance. Death is a biological concept with social implications. Acting with honesty, transparency, respect, and integrity is critical to trust in the patient–physician relationship, and the profession, in life and in death. Over time, cases about the determination of death have raised questions that need to be addressed. This American College of Physicians position paper addresses current controversies and supports a clarification to the Uniform Determination of Death Act; maintaining the 2 current independent standards of determining death, cardiorespiratory and neurologic; retaining the whole brain death standard; aligning medical testing with the standards; keeping issues about the determination of death separate from organ transplantation; reaffirming the importance and role of the dead donor rule; and engaging in educational efforts for health professionals, patients, and the public on these issues. Physicians should advocate for policies and practices on the determination of death that are consistent with the profession’s fundamental and timeless commitment to individual patients and the public.

Colonoscopy-Ascertained Prevalence of Advanced Neoplasia According to Fecal Hemoglobin Concentration in a Large Cohort of Fecal Immunochemical Test–Negative Screening Participants

Primary Care Physicians: The Bialystok Horses of Health Care?

Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease

Background: Prediction of atherosclerotic cardiovascular disease (ASCVD) in primary prevention assessments exclusively with laboratory results may facilitate automated risk reporting and improve uptake of preventive therapies. Objective: To develop and validate sex-specific prediction models for ASCVD using age and routine laboratory tests and compare their performance with that of the pooled cohort equations (PCEs). Design: Derivation and validation of the CANHEART (Cardiovascular Health in Ambulatory Care Research Team) Lab Models. Setting: Population-based cohort study in Ontario, Canada. Participants: A derivation and internal validation cohort of adults aged 40 to 75 years without cardiovascular disease from April 2009 to December 2015; an external validation cohort of primary care patients from January 2010 to December 2014. Measurements: Age and laboratory predictors measured in the outpatient setting included serum total cholesterol, high-density lipoprotein cholesterol, triglycerides, hemoglobin, mean corpuscular volume, platelets, leukocytes, estimated glomerular filtration rate, and glucose. The ASCVD outcomes were defined as myocardial infarction, stroke, and death from ischemic heart or cerebrovascular disease within 5 years. Results: Sex-specific models were developed and internally validated in 2 160 497 women and 1 833 147 men. They were well calibrated, with relative differences less than 1% between mean predicted and observed risk for both sexes. The c-statistic was 0.77 in women and 0.71 in men. External validation in 31 697 primary care patients showed a relative difference less than 14% and an absolute difference less than 0.3 percentage points in mean predicted and observed risks for both sexes. The c-statistics for the laboratory models were 0.72 for both sexes and were not statistically significantly different from those for the PCEs in women (change in c-statistic, −0.01 [95% CI, −0.03 to 0.01]) or men (change in c-statistic, −0.01 [CI, −0.04 to 0.02]). Limitation: Medication use was not available at the population level. Conclusion: The CANHEART Lab Models predict ASCVD with similar accuracy to more complex models, such as the PCEs. Primary Funding Source: Canadian Institutes of Health Research.

Receipt of Clinician Recommendation for Colorectal Cancer Screening Among Underscreened U.S. Adults

Likelihood of smoking cessation after cardiovascular event varies by event type

MKSAP Quiz: Evaluation for decreased libido, erectile dysfunction

Timing of stroke treatment, preventive therapies presented at stroke meeting

Serum urate level may predict flare risk in patients with gout

Put words in our mouth

ACP's identity campaign highlights internal medicine physicians in different settings

Decision support intervention for clinicians helped decrease low-value care

MKSAP Quiz: Evaluation after an ED visit

Insomnia symptoms, short sleep duration in midlife women linked to CVD risk

Promoting second quit attempts right after relapse may improve rates of smoking abstinence

Service animals in the hospital | ACP Hospitalist

Nosocomial COVID-19 infection, even with omicron variant, increased mortality | ACP Hospitalist

Intensive uptitration of guideline-directed medications improved HF outcomes at 90 days | ACP Hospitalist

Guidelines on diagnosing complicated intra-abdominal infections updated | ACP Hospitalist

Earlier norepinephrine for septic shock appears safe, possibly beneficial, review finds | ACP Hospitalist

Baron | ACP Hospitalist

Take a quiz about the July 3 issue! | ACP Hospitalist

Quality and inequalities in sepsis measurement | ACP Hospitalist

Pneumonia specificity | ACP Hospitalist

New model risk-adjusts sepsis patients for better mortality measurement | ACP Hospitalist